Uptake and depuration of the anti-depressant fluoxetine by the Japanese medaka (Oryzias latipes)

Chemosphere

Volumn 74, Issue 1, 2008, Pages 125-130

  Paterson, Gordon ^a   Metcalfe, Chris D ^a  

^a TRENT UNIVERSITY   (Canada)

Author keywords

Depuration; Fluoxetine; Japanese medaka; Norfluoxetine; Uptake

Indexed keywords

BIOCHEMISTRY; CONCENTRATION (PROCESS); FORECASTING; HISTOLOGY; MAMMALS; MEATS; RATE CONSTANTS; WASTEWATER; WASTEWATER TREATMENT;

DEPURATION; FLUOXETINE; JAPANESE MEDAKA; NORFLUOXETINE; UPTAKE;

WATER POLLUTION;

FLUOXETINE; NORFLUOXETINE; SEROTONIN UPTAKE INHIBITOR;

BIOACCUMULATION; BIOLOGICAL UPTAKE; DETECTION METHOD; DRUG; INHIBITOR; TELEOST;

ALKALINITY; ANIMAL TISSUE; AQUATIC ENVIRONMENT; ARTICLE; BIOACCUMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; HALF LIFE TIME; HARDNESS; MEASUREMENT; NONHUMAN; ORYZIAS; WASTE WATER; WATER QUALITY;

ANIMALS; ANTIDEPRESSIVE AGENTS; BIOLOGICAL TRANSPORT; ENVIRONMENTAL EXPOSURE; FLUOXETINE; ORYZIAS; SEROTONIN UPTAKE INHIBITORS;

MAMMALIA; ORYZIAS LATIPES; ORYZIINAE;

EID: 55649099219     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2008.08.022     Document Type: Article

References (39)

1. Avdeef A., Box K.J., Comer J.E.A., Hibbert C., and Yam K.Y. PH-metric log P 10. Determination of liposomal membrane-water partition coefficients of ionizable drugs. Pharm. Res. 15 (1998) 209-215
2. Barron G.B., Stehly G.R., and Hayton W.L. Pharmacokinetic modeling in aquatic animals I. Models and concepts. Aquat. Toxicol. 18 (1998) 61-86
3. Brooks B.W., Foran C.M., Richards S.M., Weston J., Turner P.K., Stanley J.K., Solomon K.R., Slattery M., and La Point T.W. Aquatic ecotoxicology of fluoxetine. Toxicol. Lett. 142 (2003) 169-183
4. Brooks B.W., Chambliss C.K., Stanley J.K., Ramirez A., Banks K.E., Johnson R.D., and Lewis R.J. Determination of select anti-depressants in fish from an effluent dominated stream. Environ. Toxicol. Chem. 24 (2005) 464-469
5. Brooks B.W., Riley T.M., and Taylor R.D. Water quality of effluent dominated ecosystems: ecotoxicological, hydrological, and management considerations. Hydrobiologia 556 (2006) 365-379
6. Catterson M.L., and Preskorn S.H. Pharmacokinetics of selective serotonin reuptake inhibitors: clinical relevance. Pharmacol. Toxicol. 78 (1996) 203-208
7. Christensen A.M., Faaborg-Andersen S., Ingerslev F., and Baun A. Mixture and single-substance toxicity of selective serotonin reuptake inhibitors toward algae and crustaceans. Environ. Toxicol. Chem. 26 (2007) 85-91
8. Chu S., and Metcalfe C.D. Analysis of paroxetine, fluoxetine and norfluoxetine in fish tissues using pressurized liquid extraction, mixed mode SPE cleanup and LC-MS/MS. J. Chromatogr. A 1163 (2007) 112-118
9. Daniel W.A., and Wojcikowski J. Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs. Pharmacol. Toxicol. 80 (1997) 62-68
10. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Persp. 107 (1999) 907-937
11. Escher B.I., Schwarzenbach R.P., and Westall J.W.C. Evaluation of liposome-water partitioning of organic acids and bases: I. Development of sorption model. Environ. Sci. Technol. 34 (2000) 3954-3961
12. Foran C.M., Weston J., Slattery M., Brooks B.W., and Huggett D.B. Reproductive assessment of Japanese medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure. Arch. Environ. Contam. Toxicol. 46 (2004) 511-517
13. Hemeryck A., Eng C.d.V., and Belpaire F.M. Effect of selective serotonin reuptake inhibitors on the oxidative metabolism of propafenone: in vitro studies using human liver microsomes. J. Clin. Psychopharmacol. 20 (2000) 428-434
14. Henry T.B., and Black M.C. Mixture and single-substance acute toxicity of selective serotonin reuptake inhibitors in Ceriodaphina dubia. Environ. Toxicol. Chem. 26 (2007) 1751-1755
15. Hermens J.L.M., and Verhaar H.J.M. QSARs in environmental toxicology and chemistry. In: Hansch C., and Fujita T. (Eds). Classical and Three-Dimensional QSAR in Agrochemistry vol. 606 (1995), American Chemical Society, Washington, DC, USA 130-140
16. Hiemke C., and Härtter S. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol. Therap. 85 (2000) 11-28
17. Huggett D.B., Cook J.C., Ericson J.F., and Williams R.T. A theoretical model for utilizing mammalian pharmacology and safety data to prioritize potential impacts of human pharmaceuticals to fish. Hum. Ecol. Risk Assess. 9 (2003) 1789-1799
18. Huggett D.B., Ericson J.F., Cook J.C., and Williams R.T. Plasma concentrations of human pharmaceuticals as predictors of pharmacological responses in fish. In: Kümmereer K. (Ed). Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks (2004), Springer, Berlin, Germany 373-385
19. Johnson D.J., Sanderson H., Brain R.A., Wilson C.J., Bestari K.T., and Solomon K.R. Exposure assessment and microcosm fate of selective serotonin reuptake inhibitors. Reg. Toxicol. Pharmacol. 42 (2005) 313-323
20. Kolpin D., Meyer F., Thurman M.T., Zaugg S.D., Barber L.B., and Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36 (2002) 1202-1211
21. Kwon J.W., and Armbrust K.L. Laboratory persistence and fate of fluoxetine in aquatic environments. Environ. Toxicol. Chem. 25 (2006) 2561-2568
22. Lienert J., Güdel K., and Escher B.I. Screening method for ecotoxicological hazard assessment of 42 pharmaceuticals considering human metabolism and excretory routes. Environ. Sci. Technol. 41 (2007) 4471-4478
23. Lindberg R.H., Wennberg P., Johannson M.I., Tyslind M., and Andersson B.A.V. Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden. Environ. Sci. Technol. 39 (2005) 3421-3429
24. Mackay D., and Fraser A. Bioaccumulation of persistent organic chemicals: mechanisms and models. Environ. Pollut. 110 (2000) 375-391
25. MacLeod S.L., Sudhir P., and Wong C.S. Stereoisomer analysis of wastewater derived β-blockers, selective serotonin re-uptake inhibitors, and salbutamol by high-performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 1170 (2007) 23-33
26. Metcalfe C.D., Miao X.S., Koenig B.G., and Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ. Toxicol. Chem. 22 (2003) 2881-2889
27. Mimeault C., Woodhouse A.J., Miao X.-S., Metcalfe C.D., Moon T.W., and Trudeau V.L. The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquatic. Toxicol. 73 (2005) 44-54
28. Nakamura Y., Yamamoto H., Sekizawa J., Kondo T., Hirai N., and Tatarakazo N. The effects of pH in Japanese medaka (Oryzias latipes): acute toxicity in fish larvae and bioaccumulation in juvenile fish. Chemosphere 70 (2008) 865-873
29. NDC Health, 2008. The internet drug index (the top 200 prescriptions of 2006). (cited March 28 2008).
30. Nendza M., and Russom C. QSAR modeling of the ERL-D fathead minnow acute toxicity database. Xenobiotica 21 (1991) 147-170
31. Perrault H.A.N., Semsar K., and Godwin J. Fluoxetine treatment decreases territorial aggression in a coral reef fish. Physiol. Behav. 79 (2003) 719-724
32. Preskorn S.H. Clinical pharmacology of selective serotonin reuptake inhibitors (1996), Professional Communications Inc., Caddo, OK, USA
33. Scherrer R.A. The treatment of ionizable compounds in quantitative structure-activity studies with special consideration to ion partitioning. In: Magee P.S., Kohn G.K., and Menn J.J. (Eds). Pesticide Synthesis through Rational Approaches vol. 255 (1984), ACS Symposium Series, Washington, DC 225-246
34. Schultz M., and Furlong E.T. Trace analysis of antidepressant pharmaceuticals and their select degradates in aquatic matrixes by LC/ESI/MS/MS. Anal. Chem. 80 (2008) 1756-1762
35. Stanley J.K., Ramirez A.J., Chambliss C.K., and Brooks B.W. Enantiospecific sublethal effects of the antidepressant fluoxetine to a model aquatic vertebrate and invertebrate. Chemosphere 69 (2007) 9-16
36. SYSTAT, 2004. SYSTAT for Windows version 11.0. SYSTAT Software Inc. Richmond, CA.
37. Weston, J., Huggett, D.B., Rimoldi, J., Foran, C.M., Slattery, M., 2001. Determination of fluoxetine (Prozac™) and norfluoxetine in the aquatic environment. In: Proc. 22nd Annual Meeting of the Society of Environmental Toxicology and Chemistry, Baltimore, MD, USA, p. 353.
38. Zar J. Biostatistical Analysis. second ed. (1984), Prentice Hall Inc., Engle Wood Cliffs, NJ
39. Zorita S., Mårtensson L., and Mathiasson L. Hollow-fibre supported liquid membrane extraction for the determination of fluoxetine and norfluoxetine concentration at ultra trace level in sewage samples. J. Sep. Sci. 30 (2007) 2513-2521